Enterobacter spp. especially Enterobactercloacae are frequent cause of neonatal sepsis in humans. In this study, the occurrence and characteristics of multidrug resistant-extended-spectrum β-lactamase (MDR-ESBL) producing Enterobacter spp. isolated from live and dead poultry of Savar, Bangladesh were investigated. Between May 2009 and June 2011, 106 samples derived from live and dead birds were collected of which 22 presumptive Enterobacter isolates were screened through phenotypic (morphological, cultural and biochemical) detection. Antibiogram against 10 commonly used antibiotics revealed that all isolates were resistant to Amoxicillin, Ampicillin, Penicillin, and Erythromycin. Furthermore, resistance pattern showed by the isolates were Nitrofurantoin (19, 95%), Gentamycin (11, 55%), Streptomycin (18, 95%), Sulfonamides (13, 65%), Tetracyclines (15, 75%) and Ciprofloxacin (12, 60%). Genetic fingerprinting methods RAPD (randomly amplified polymorphic DNA) and ARDRA (arbitrary ribosomal DNA restriction analysis) distributed the 22 MDR Enterobacter into four groups. Three genetically related groups were found to be plasmid free having isolates resistant to 10 antibiotics. One distinct group of Enterobacter with four isolates contains a common 2.7 kb plasmid, encoding bla TEM1 gene. The genotypically diverse groups belonged to either Enterobacter cloacae or Enterobacter hormaechei on the basis of 16S rRNA gene sequence analysis indicating their zoonotic potential. The prevalence of MDR-ESBL Enterobacter among poultry and its zoonotic relevance implicates not only the poultry but also the consumers and handlers are at risk. Therefore, urgent intervention is required to limit the emergence and spread of these bacteria as well as prudent use of antibiotics among farmers in Bangladesh.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.